Reviva Pharmaceuticals (RVPH) Earnings Date, Estimates & Call Transcripts $1.31 -0.07 (-5.07%) (As of 09/19/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 12EstimatedActual EPS (Aug. 14) -$0.26 Beat By $0.02 Consensus EPS (Aug. 14) -$0.28 Get Reviva Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RVPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRVPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RVPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceHave you heard of this 5-Day Challenge yet?You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go Reviva Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.28)($0.28)($0.28)Q2 20241($0.28)($0.28)($0.28)Q3 20241($0.25)($0.25)($0.25)Q4 20241($0.26)($0.26)($0.26)FY 20244($1.07)($1.07)($1.07)Q1 20251($0.26)($0.26)($0.26)Q2 20251($0.27)($0.27)($0.27)Q3 20251($0.22)($0.22)($0.22)Q4 20251($0.18)($0.18)($0.18)FY 20254($0.93)($0.93)($0.93)RVPH Earnings Date and InformationReviva Pharmaceuticals last issued its earnings results on August 14th, 2024. The reported ($0.26) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.28) by $0.02. Reviva Pharmaceuticals has generated ($1.59) earnings per share over the last year (($1.59) diluted earnings per share). Earnings for Reviva Pharmaceuticals are expected to grow in the coming year, from ($0.98) to ($0.81) per share. Reviva Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off prior year's report dates.Read More Reviva Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Estimated)------- 8/14/2024-($0.28)($0.26)+$0.02($0.26)--5/14/2024Q1 2024($0.28)($0.25)+$0.03($0.25)--4/15/2024Q4 2023-($0.35)($0.35)($0.35)--11/14/2023Q3 2023($0.35)($0.44)($0.09)($0.44)--8/14/2023Q2 2023($0.29)($0.55)($0.26)($0.55)--5/15/2023Q1 2023($0.36)($0.30)+$0.06($0.30)-- Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022($0.23)($0.38)($0.15)($0.38)--11/14/2022Q3 2022($0.30)($0.18)+$0.12($0.18)--8/15/2022Q2 2022($0.31)($0.29)+$0.02($0.29)--5/16/2022Q1 2022($0.28)($0.40)($0.12)($0.40)--3/15/2022Q4 2021($0.24)($0.24)-($0.26)--11/15/2021Q3 2021($0.23)($0.12)+$0.11($0.12)--8/16/2021Q2 2021($0.24)($0.12)+$0.12($0.12)--5/17/2021Q1 2021-($0.10)($0.10)($0.10)--3/22/2021Q4 2020-($0.84)($0.84)($0.84)--1/14/2021Q3 2021-($0.13)($0.13)($0.13)--10/14/2020Q2 2021-($0.19)($0.19)($0.19)--7/7/2020Q1 2021-($0.09)($0.09)($0.09)--5/4/2020Q4 2020-($0.13)($0.13)($0.13)--1/10/2020Q3 2020-($0.05)($0.05)($0.05)--10/8/2019Q2 2020-($0.02)($0.02)($0.02)-- Reviva Pharmaceuticals Earnings - Frequently Asked Questions When is Reviva Pharmaceuticals's earnings date? Reviva Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on RVPH's earnings history. Did Reviva Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Reviva Pharmaceuticals (NASDAQ:RVPH) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.28) by $0.02. Learn more on analysts' earnings estimate vs. RVPH's actual earnings. How much profit does Reviva Pharmaceuticals generate each year? Reviva Pharmaceuticals (NASDAQ:RVPH) has a recorded net income of -$39.26 million. RVPH has generated -$1.59 earnings per share over the last four quarters. What is Reviva Pharmaceuticals's EPS forecast for next year? Reviva Pharmaceuticals's earnings are expected to grow from ($0.98) per share to ($0.81) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PRQR Earnings LFCR Earnings ADVM Earnings ME Earnings CRDL Earnings ELUT Earnings OPTN Earnings RANI Earnings FBLG Earnings IMUX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:RVPH) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.